Brief: Yumanity Therapeutics Declares Special Dividend In Connection With Proposed Asset Sale To Janssen, Merger With Kineta
Dec 5 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS DECLARES SPECIAL DIVIDEND IN
CONNECTION
WITH PROPOSED ASSET SALE TO JANSSEN AND MERGER WITH KINETA
* YUMANITY THERAPEUTICS INC - SPECIAL DIVIDEND ESTIMATED TO
BE IN
RANGE OF $1.34 TO $1.43 PER SHARE
* YUMANITY THERAPEUTICS - PAYMENT OF SPECIAL DIVIDEND
CONDITIONED
UPON CLOSING OF BOTH ASSET SALE AND MERGER, WHICH ARE SUBJECT TO
STOCKHOLDER APPROVAL
Source text for Eikon: ID:nGNX688hgj
Further company coverage: YMTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study